Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Keiko Udaka"'
Autor:
Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Hiroshi Hamana, Yoshihiko Goto, Yoshiki Aritsu, Yusuke Miyashita, Hiroyuki Oshiumi, Kimitoshi Nakamura, Seiji Okada, Keiko Udaka, Mizuki Kitamatsu, Hiroyuki Kishi, Takamasa Ueno
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Mutations in the spike of SARS-CoV-2 can result in the escape of the neutralising antibody response but may retain susceptibility to the cellular immune response. Here the authors show the G446S mutation in the spike protein of Omicron BA.1 is associ
Externí odkaz:
https://doaj.org/article/8c5c5a990c0e4b02b5f94e360a145608
Publikováno v:
Molecules, Vol 21, Iss 10, p 1284 (2016)
To establish peptide vaccine-based cancer immunotherapy, we investigated the improvement of antigenic peptides by encapsulation with pH-sensitive fusogenic polymer-modified liposomes for induction of antigen-specific immunity. The liposomes were prep
Externí odkaz:
https://doaj.org/article/d422cfc8e1a24307b158504e30213ccd
Autor:
Masao Nakajima, Shoichi Hazama, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Yuki Nakagami, Koji Tamada, Keiko Udaka, Michiie Sakamoto, Akira Saito, Yasunari Kouki, Toshinari Uematsu, Ming Xu, Michihisa Iida, Ryouichi Tsunedomi, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, Shun Doi, Hiroaki Nagano
Publikováno v:
Hepatology Research.
Autor:
Akihiro Tsuboi, Haruo Sugiyama, Shinji Sogo, Naoki Hosen, Kanako Imafuku, Kana Hasegawa, Sumiyuki Nishida, Soyoko Morimoto, Keiko Udaka, Kazuki Isokawa, Fumihiro Fujiki, Jun Nakata, Yusuke Oji, Hiroko Nakajima, Yoshiko Hashii, Hiromu Hayashibara, Yoshihiro Oka
Publikováno v:
Cancer Immunology, Immunotherapy. 70:3323-3335
Helper T lymphocytes (HTLs) play a central role in cancer immunity because they can not only help the induction and proliferation of cytotoxic T lymphocytes (CTLs) but also their differentiation into cytotoxic CD4+ T cells and directly kill the targe
Publikováno v:
Journal of the American College of Cardiology. 81:421
Autor:
Eiji Yuba, Yoshikatsu Sugahara, Kenji Kono, Takeyuki Shimizu, Keiko Udaka, Michiyuki Kasai, Yuta Yoshizaki
Publikováno v:
Biomaterials Science. 9:3076-3089
application/pdf
Biomaterials Science. 2021, 9 (8), P.3076-3089
Biomaterials Science. 2021, 9 (8), P.3076-3089
Autor:
Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Hiroshi Hamana, Yoshiki Aritsu, Yusuke Miyashita, Hiroyuki Oshiumi, Kimitoshi Nakamura, Seiji Okada, Keiko Udaka, Mizuki Kitamatsu, Hiroyuki Kishi, Takamasa Ueno
Although the Omicron variant of the SARS-CoV-2 virus is resistant to neutralizing antibodies, it retains susceptibility to cellular immunity. Here, we characterized vaccine-induced T cells specific for various SARS-CoV-2 variants and identified HLA-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89cc85fc48b817a51dd9ac519b59476f
https://doi.org/10.1101/2022.04.17.488095
https://doi.org/10.1101/2022.04.17.488095
Autor:
Shin Yoshida, Akira Saito, Nobuaki Suzuki, Yuki Nakagami, Hiroto Matsui, Koji Tamada, Michihisa Iida, Hiroaki Nagano, Masao Nakajima, Shigefumi Yoshino, Shigeru Takeda, Toshinari Uematsu, Hideki Arima, Yasunobu Kouki, Tomio Ueno, Satoshi Matsukuma, Shinobu Tomochika, Shigeru Yamamoto, Shun Doi, Keiko Udaka, Yoshitaro Shindo, Yukio Tokumitsu, Shoichi Hazama, Shinsuke Kanekiyo
Publikováno v:
Cancer Immunology, Immunotherapy
Background This phase I study aimed to evaluate the safety, peptide-specific immune responses, and anti-tumor effects of a novel vaccination therapy comprising multi-HLA-binding heat shock protein (HSP) 70/glypican-3 (GPC3) peptides and a novel adjuv
Autor:
Sayo Kataoka, Keiko Udaka, Toshihiro Komatsu, Rika Fujimoto, Kaori Machida, Makoto Kanoh, Yoshiki Yasukochi, Takeyuki Shimizu, Tomoya Miyakawa, Motoki Tada, Yoko Satta
Publikováno v:
Immunogenetics. 72:143-153
Specificity analyses of peptide binding to human leukocyte antigen (HLA)-A molecules have been hampered due to a lack of proper monoclonal antibodies (mAbs) for certain allomorphs, such as the prevalent HLA-A1 for Caucasians and HLA-A11 for Asians. W
Autor:
Koji Nagaoka, Changbo Sun, Yukari Kobayashi, Takayuki Kanaseki, Serina Tokita, Toshihiro Komatsu, Kazuhiro Maejima, Junichiro Futami, Sachiyo Nomura, Keiko Udaka, Hidewaki Nakagawa, Toshihiko Torigoe, Kazuhiro Kakimi
Publikováno v:
Cancers
Cancers, Vol 14, Iss 106, p 106 (2022)
Cancers; Volume 14; Issue 1; Pages: 106
Cancers, Vol 14, Iss 106, p 106 (2022)
Cancers; Volume 14; Issue 1; Pages: 106
Simple Summary Despite the success of immune checkpoint inhibitors (ICI) for treating a variety of solid cancers, most gastric cancer patients are resistant to ICI monotherapies. Combinations of ICI with other therapies may be able to overcome this r